OLMETTO, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 1.279
EU - Europa 729
AS - Asia 231
AF - Africa 4
OC - Oceania 1
Totale 2.244
Nazione #
US - Stati Uniti d'America 1.274
RU - Federazione Russa 376
IT - Italia 120
PL - Polonia 77
IE - Irlanda 73
CN - Cina 69
SG - Singapore 62
HK - Hong Kong 58
SE - Svezia 37
JO - Giordania 19
DE - Germania 15
IN - India 12
FI - Finlandia 10
GB - Regno Unito 8
KR - Corea 7
CA - Canada 5
CZ - Repubblica Ceca 5
CI - Costa d'Avorio 3
FR - Francia 3
CH - Svizzera 2
UA - Ucraina 2
VN - Vietnam 2
AU - Australia 1
BE - Belgio 1
LK - Sri Lanka 1
MU - Mauritius 1
PH - Filippine 1
Totale 2.244
Città #
Santa Clara 256
Fairfield 172
Ashburn 83
Seattle 79
Chandler 78
Warsaw 77
Dublin 73
Woodbridge 72
Wilmington 57
Cambridge 56
Houston 51
Dearborn 49
Singapore 47
Hong Kong 44
Ann Arbor 28
Florence 23
Beijing 22
Lawrence 21
Altamura 17
Princeton 17
Moscow 16
New York 16
Buffalo 15
San Diego 15
Shanghai 15
Kent 9
Medford 9
Mumbai 9
Boston 7
Los Angeles 7
Munich 7
Seoul 7
Rome 6
West Jordan 6
Brno 5
Helsinki 5
Guangzhou 4
Nanjing 4
Abidjan 3
Boardman 3
Falls Church 3
Hefei 3
Lappeenranta 3
Pontedera 3
Taranto 3
Toronto 3
Bergamo 2
Bern 2
Bojano 2
Calgary 2
Civitella del Tronto 2
Dong Ket 2
Empoli 2
Falkenstein 2
Kunming 2
Norwalk 2
Palombara Sabina 2
Redwood City 2
Scarperia e San Piero 2
Shenzhen 2
Southwark 2
Wuhan 2
Wuxi 2
Yubileyny 2
Atlanta 1
Bari 1
Brentford 1
Brussels 1
Changchun 1
Chengdu 1
Chongqing 1
Colle di Val d'Elsa 1
Colombo 1
Delhi 1
Frankfurt am Main 1
Fremont 1
Gate City 1
Genoa 1
Gorgonzola 1
Handan 1
Hangzhou 1
Hillsboro 1
Jinan 1
Kumar 1
Kyiv 1
London 1
Nagold 1
New Bedfont 1
Nürnberg 1
Palermo 1
Paris 1
Phoenix 1
Ponte Buggianese 1
Portland 1
Pune 1
Quezon City 1
Ragusa 1
Romola 1
San Genesio Ed Uniti 1
San Mateo 1
Totale 1.580
Nome #
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis 206
Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment 149
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 147
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 130
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors? 129
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 127
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 126
Radiotherapy in the age of cancer immunology: Current concepts and future developments 122
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 120
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 113
Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study 110
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 100
Dosimetric Predictors of Acute and Chronic Alopecia in Primary Brain Cancer Patients Treated With Volumetric Modulated Arc Therapy 94
Prognostic impact of nodal relapse in definitive prostate-only irradiation 90
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO 68
Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery 63
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 62
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 59
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 55
Lobectomy vs Stereotactic Ablative Radiotherapy in NSCLC: a multicentric series in four centers 55
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 44
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression 41
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 38
Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis 22
Totale 2.270
Categoria #
all - tutte 7.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020371 0 0 0 0 64 69 71 51 43 27 28 18
2020/2021165 15 14 9 19 9 12 4 11 17 29 19 7
2021/2022125 2 12 11 5 3 8 5 12 5 9 19 34
2022/2023338 26 74 20 9 21 60 44 20 42 3 10 9
2023/2024252 11 15 22 16 16 38 16 61 6 23 21 7
2024/2025800 46 113 75 240 326 0 0 0 0 0 0 0
Totale 2.270